The crystal structure of the title compound, C 19 H 26 NO + ÁCl À (common name: N,N-diethyl-2-[(4-phenylmethyl)phenoxy]-ethanamine hydrochloride), contains one molecule in the asymmetric unit. The planes through the two phenyl rings are roughly perpendicular. Protonation occurs at the N atom, to which the Cl À ion is linked via an NÐHÁ Á ÁCl hydrogen bond. The molecule adopts an eclipsed rather than extended conformation.
Comment
[2-(4-Benzylphenoxy)ethyl]diethylammonium chloride, (I), is a diphenylmethane analogue of the antiestrogen tamoxifen which antagonizes the binding of histamine to intracellular growth-regulatory sites associated with antiestrogen-binding sites in microsomes and nuclei. It has been found that (I) increases the therapeutic index of some chemotherapy drugs, with the added bene®t of lower toxicity to normal tissue like bone marrow, gut and hair, and the compound has been studied as a treatment for metastatic prostate cancer (Brandes et al., 1994 (Brandes et al., , 1995 . A chemopotentiating effect of the drug in patients with early metastatic breast cancer has also been observed (Brandes & Bracken, 1998) , and growth-inhibitory effects on human ovarian cancer cells when combined with cisplatin have been reported by Hiramatsu et al. (1997) . Since knowledge of the stereochemistry is useful in the rational design of drugs with enhanced chemotherapeutic effects and lower toxicities, we now report on the three-dimensional structure of (I).
The molecular conformation in the crystal (Fig. 1) consists of two phenyl rings and an N,N-diethyl side chain in an eclipsed conformation. The best planes through the phenyl rings intersect at an angle of 79.12 (12) . In the closely related compounds clomiphene hydrochloride (Ernst & Hite, 1976) , and tamoxifen (Precigoux et al., 1979) . The molecular bond distances and angles are consistent with the normal values. The C12ÐC11ÐO14ÐC15, C11ÐO14ÐC15ÐC16, O14ÐC15ÐC16ÐN17 and C15Ð C16ÐN17ÐC20 torsion angles are 178.2 (3), 169.7 (2), 73.9 (3) and À80.3 (3)
, respectively. Similar values were found in clomiphene (Ernst & Hite, 1976) . In the crystal structure of (I) the molecules lie virtually parallel to the b axis, with only van der Waals contacts between them. Fig. 2 shows the crystal structure conformation of (I) superimposed with that of clomiphene. The corresponding parts of the two molecules overlap closely; only small rotations about single bonds would be required for total overlap. The same situation holds for (I) and tamoxifen, as tamoxifen and clomiphene have been shown to share conformational and stereochemical features (Camerman et al., 1980) . It may be that this part of the molecular structure is responsible for the Acta Cryst. common antiestrogen properties of these molecules and the third phenyl ring, absent in (I), may be involved in other antiproliferative actions of three-ring antiestrogens on cancer cells (Lavie et al., 1998) independent of estrogen receptors.
Experimental
Crystals of (I) were obtained as very small needles by solvent evaporation from an ethanol/ethyl acetate mixture. Due to the small size of the available crystals, data were collected on the synchrotron at NSLS (Brookhaven). The SHELX97 (Sheldrick, 1997) instructions TWIN and BASF were included; the Flack parameter is the volume fraction of one of the individuals of the racemic twin.
Crystal data
Data collection: DENZO-SMN (Otwinowski & Minor, 1997) ; cell re®nement: DENZO-SMN; data reduction: DENZO-SMN; program(s) used to solve structure: SHELX97; program(s) used to re®ne structure: SHELX97; molecular graphics: ORTEP3 for Windows (Farrugia, 1997) ; software used to prepare material for publication: SHELX97.
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